http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20073491-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e53fa2c52b9674f40cfca71433b6253
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-195
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2007-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82a5ff51ffedce1d99555329a88c1f9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_548278fc9d1cb57fbaa40c4246f9a0f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3f5b9feec67e231e6114e35262466cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_939a225bf2a2c6a690dfa67034facd77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2680d6058b2c6461a9cfda6fecd5e99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a493989e520ff0d9c9a3dd483a555633
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11654ec6ad8cee769b9a44d29bdc1ca3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77a2625bf2746f1ae819f46c8e06717e
publicationDate 2007-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20073491-L
titleOfInvention Antibiotic 107891, its factors A1 and A2, as well as pharmaceutically acceptable salts and compositions, and uses thereof
abstract It describes an antibiotic substance of microbial origin, arbitrarily named antibiotic 107891, which is produced by fermentation of Microbispora sp. ATCC PTA-5024, pharmaceutically acceptable salts and compositions thereof, and their use as an antibacterial agent having an inhibitory activity against susceptible microbes. Antibiotic 107891, which is a complex comprising two factors, called factor A1 and factor A2, has a peptide structure containing lanthionine and methyllanthionine as constituents and which are typical characteristics of antibiotics of the lantibiotic group. Antibiotic 107891 and its factors Al and A2 show good antibacterial activity against Gram-positive bacteria including methicillin-resistant and vancomycin-resistant strains, and are also active against some Gram-negative bacteria such as M. catharralis, Neisseria species and H. infiuenzae and Mycobacteria.
priorityDate 2005-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426285185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72715788
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6087

Total number of triples: 23.